Mitochondria-lysosome crosstalk in GBA1-associated Parkinson's disease.

Sahyadri, M; Nadiga, Abhishek P R; Mehdi, Seema; Mruthunjaya, K; Nayak, Pawan G; Parihar, Vipan K; Manjula, S N

Sahyadri, M; Nadiga, Abhishek P R; Mehdi, Seema; Mruthunjaya, K; Nayak, Pawan G; Parihar, Vipan K; Manjula, S N.

Afiliación

Sahyadri M; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015 Karnataka India.
Nadiga APR; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015 Karnataka India.
Mehdi S; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015 Karnataka India.
Mruthunjaya K; Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015 Karnataka India.
Nayak PG; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal, 576104 Karnataka India.
Parihar VK; Department of Pharmacology and Toxicology, NIPER-Hajipur, Bihar, 844102 India.
Manjula SN; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015 Karnataka India.

3 Biotech ; 12(9): 230, 2022 Sep.

Article en En | MEDLINE | ID: mdl-35992895

Palabras clave

Glucosylceramidase Beta (GBA); Lysosome; ML crosstalk; Mitochondria; Neuronal dysfunction; Parkinson's disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: 3 Biotech Año: 2022 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google